Lidocaine (topical) vs CYP2D6 Substrates

Interacting Drugs
Lidocaine (topical)
vs
CYP2D6 Substrates
Security Level
Minor, Monitor Therapy
Mechanism
CYP2D6 Substrates: CYP2D6 Inhibitors (Moderate) may decrease the metabolism of CYP2D6 Substrates. Exceptions: Tamoxifen.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Lidocaine (topical) vs CYP2D6 Substrates